InvestSMART

Hydrix Limited (ASX: HYD) - Announcements

- Current share price for HYD : $0.003

ASX company news and announcements for Hydrix Limited (HYD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Hydrix Limited (HYD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Hydrix Limited (HYD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Hydrix Limited (HYD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2026 5:39PM $0.003 $0.003 fallen by 16.67%
$4 Corporate Governance Statement and Appendix 4G 27 Oct 2026 10:27AM $0.003 $0.003 fallen by 16.67%
$4 FY26 Annual Report to shareholders 27 Oct 2026 10:23AM $0.003 $0.003 fallen by 16.67%
$4 Notice of 2026 Annual General Meeting/Proxy Form 27 Oct 2026 10:20AM $0.003 $0.003 fallen by 16.67%
$4 Cleansing Notice 15 Oct 2026 4:15PM $0.003 $0.003 fallen by 16.67%
$4 Application for quotation of securities - HYD 15 Oct 2026 4:07PM $0.003 $0.003 fallen by 16.67%
$4 Notification regarding unquoted securities - HYD 15 Oct 2026 3:38PM $0.003 $0.003 fallen by 16.67%
$4 Notification of cessation of securities - HYD 15 Oct 2026 3:27PM $0.003 $0.003 fallen by 16.67%
$4 HYD delivers 1st prototype to NIOA for counter-drone program 5 Oct 2026 9:00AM $0.003 $0.003 fallen by 16.67%
$4 FY26 Financial Report 30 Sep 2026 3:42PM $0.003 $0.003 fallen by 16.67%
$4 2026 AGM Date and Closing Date of Director Nominations 30 Sep 2026 3:39PM $0.003 $0.003 fallen by 16.67%
$4 Hydrix Medical contract with National Heart Centre Singapore 17 Sep 2026 9:52AM $0.003 $0.003 fallen by 16.67%
$4 Hydrix Advancing Strategic Defence Activities 31 Aug 2026 9:13AM $0.004 $0.003 fallen by 28.57%
$4 Letter from Chairman 28 Aug 2026 2:59PM $0.004 $0.003 fallen by 28.57%
$4 Preliminary Final Report 28 Aug 2026 2:55PM $0.004 $0.003 fallen by 28.57%
$4 Hydrix Executive Chair discusses growth strategy on ausbiz 19 Aug 2026 11:17AM $0.003 $0.003 fallen by 16.67%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 6:14PM $0.004 $0.003 fallen by 28.57%
$4 Remedy Robotics awards HYD A$3.4M Surgical Robotics Contract 20 Jul 2026 9:29AM $0.004 $0.003 fallen by 37.50%
$4 Becoming a substantial holder 24 Jun 2026 3:21PM $0.003 $0.003 fallen by 16.67%
$4 Hydrix engaged to advance next-gen stroke therapy platform 24 Jun 2026 8:23AM $0.004 $0.003 fallen by 28.57%
$4 Application for quotation of securities - HYD 22 Jun 2026 5:50PM $0.004 $0.003 fallen by 37.50%
$4 Notification of cessation of securities - HYD 22 Jun 2026 5:46PM $0.004 $0.003 fallen by 37.50%
$4 Ceasing to be a substantial holder 19 Jun 2026 5:24PM $0.004 $0.003 fallen by 37.50%
$4 Ceasing to be a substantial holder 19 Jun 2026 5:00PM $0.004 $0.003 fallen by 37.50%
$4 Reinstatement of security class- HYDOC 19 Jun 2026 8:53AM $0.004 $0.003 fallen by 37.50%

1 - 25 of 509 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.